The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life...
Visium has grown to a team of 100 AI experts across Europe and has delivered more than 250 AI and data solutions for global leaders in life sciences, specialty chemicals and other regulated industries...
Sermes CRO is a Spanish contract research organization (CRO) with 29 years of experience, dedicated to optimizing clinical research processes for pharmaceutical and biotechnology companies, as well as...
Syngoi Technologies has developed in recent years its own enzymatic synthetic DNA platform, designed to address one of the key structural challenges in the gene and cell therapy industry: the efficien...
The company has developed an advanced computational platform, combined with high-throughput experimentation, that uses proprietary methods to design multifunctional de novo proteins. These proteins, b...
The Series B extension financing was led by Bpifrance and joined by all existing shareholders, including AdBio Partners, CDTI Innovación, Columbus Venture Partners, European Innovation Council (EIC),...
Columbus Life Sciences Fund V will primarily invest in European and U.S.-based technology companies in the fields of biotechnology, advanced therapies, medical devices, precision medicine, diagnostics...
The Columbus Venture Partners team, strategic investor in the development of BO-112, celebrates this new clinical milestone as a validation of the company’s scientific and business strategy, while a...
The round was co-led by prominent investors Columbus Venture Partners, Panakès Partners, and Mérieux Equity Partners. The financing round also had strong participation from existing investors Asabys...
Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose-limiting toxicity, today announced that it has secured a $30 million fin...
Esta cita, única en España, ha concentrado el foco de atención en torno a la inteligencia artificial (IA) aplicada a la salud debido al enorme potencial para revolucionar el diagnóstico, tratamien...
Tolerance Bio is developing an allogeneic, or “off the shelf,” thymus induced pluripotent stem cell (iPSC)-based cell therapy platform as well as pharmacological thymus therapies to address immune...